Updated On: 17 December, 2021 07:43 PM IST | New Delhi | IANS
'The study was conducted using sera with a longer period after vaccination (more than 6 months after vaccination) as an indicator of Sputnik V's long-lasing protection, in contrast with short studied periods for other vaccines producers (12-27 days for Pfizer-BioNTech and 28 days for Moderna),' the Gamaleya Center said in a statement

This picture has been used for representational purpose
The Sputnik V vaccine and the one-shot Sputnik Light booster are effective against the vaccine-evading and super mutant Omicron variant of Covid-19, claimed a preliminary laboratory study conducted by Russia's Gamaleya Center.
The study shows that Sputnik V demonstrates high virus neutralising activity against the Omicron variant and is expected to provide a strong defence against severe disease and hospitalisation.